Buy, Sell or Hold: Teladoc Inc (TDOC-N) — Stock Predictions at Stockchase

NYSE:TDOC

32.85

1.12 (3.53%) 1d

Showing 1 to 15 of 34 entries

DON'T BUY

Business appears to be turning around. Recent selloff might create opportunity, but would not recommend buying.

Healthcare

DON'T BUY

Both sides of the mountain, the rocket and the torpedo. Valuation was always too rich for him. Impacted by shift away from high growth. Telehealth needs an integrated network, and the big guys like UNH can so easily provide this.

Healthcare

DON'T BUY

TDOC vs. QQQ vs. SOXX QQQ and SOXX, he has no idea where the market's going to be next month, next quarter, or this year. All he knows is that there's going to be a lot of volatility. So it's an environment of less investing, more trading. Have to be nimble, active. SOXX charts very well, it's the DOW modern day Transport Index, so you need to watch it. He was in TDOC a year ago, and backed away. Healthcare and biotech have had a difficult time.

Healthcare

DON'T BUY

He sold. Rough technically. A lot of money moved out of the pandemic names. Down 72%. Be careful, as he doesn't see the momentum changing right away. Need stronger earnings prints and better valuation for him. 5.5x price to sales, pretty expensive. Interest rates will be hard on those with strong revenue growth but no profit.

Healthcare

BUY on WEAKNESS

We will likely see more growth in healthcare, namely in rural areas, so TDOC is positioned well. But this stock will be pressured in coming months, because of its high PE. If you enter any high-PE stock, buy just a partial position then add on volatility. TDOC is down 28% from its high.

Healthcare

COMMENT

Inclined to sell the stock. Even with the recent pullback on the stock, company is still over valued. Not anywhere close to generating cash flow or revenue. Investors must be wary of how far valued stocks can fall.

Healthcare

WATCH

Remote healthcare will continue after Covid. Teladoc shot up last year, but when Cathy Wood moved out, her followers did and it oversold. The company is not wounded at all, but this industry will be fine long-term. This stock could go a lot lower, but this is a good idea.

Healthcare

SELL

Great story. World's largest platform for online healthcare. Price target of $161. Down 50% from all-time highs, puzzling. Intellectual property is very solid, so he's not sure if it's mismanaged. It all comes down to execution. He had a stop on it, and got out of the way. Investors should do the same.

Healthcare

Unlock the Weekly Buzzing Stocks

Become a member Or, Sign In

TOP PICK

The valuation had been stretched and it has seen some volatility. There has been some consolidation. The future continues to make sense for companies like this. A disruptor with long-term growth potential. Social media mentions are up 73% over the last 24 hours.

Healthcare

WAIT

Big runup last year during Covid. Valuation got stretched. Volatile. Theme of the business makes some sense. Suffering from lots of action in the options market. Stay away for now until the volatility dies down.

Healthcare

HOLD

Rough ride. Acquisitions, growing pains, disappointing results. Future of these names continues to make sense. Be patient. Chart looks as though it's basing. Higher growth name, so hurt by threat of rising rates. A disruptor, long-term growth, we'll see ups and downs. Put your stop losses in place.

Healthcare

WATCH

It is a leader in US healthcare. He looked at them. They did a big merger and the stocks have pulled back. He had difficulty with it. They are still losing money. Watch it until it becomes more mature.

Healthcare

WATCH

Great run at start of pandemic. Difficulty is newer contracts are with health insurers, so margins are lower. Not as sticky a service as you might think. You can join, and then unjoin. Hasn't held up. Stock's a bit broken. Need to see price pattern improve and subscriber base more stable.

Healthcare

PAST TOP PICK

(A Top Pick Aug 26/20, Down 30%) Typical stay-at-home name. Growing pains. Last quarter had a wider loss than expected. Still sees 25% revenue growth per year. User base and revenue continue to grow. Valuation is a bit expensive. He's being patient, it's the way of the future.

Healthcare

HOLD

Price target is $166.85. Platform to get healthcare from a variety of professionals. Has grown revenue significantly, leader in the category of med-tech. Volatile. Yet to be profitable. A number of acquisitions. Still likes it.

Healthcare

Showing 1 to 15 of 34 entries

Teladoc Inc(TDOC-N) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 2

Bearish - Sell Signals / Votes : 6

Total Signals / Votes : 10

Stockchase rating for Teladoc Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Teladoc Inc(TDOC-N) Frequently Asked Questions

What is Teladoc Inc stock symbol?

Teladoc Inc is a American stock, trading under the symbol TDOC-N on the New York Stock Exchange (TDOC). It is usually referred to as NYSE:TDOC or TDOC-N

Is Teladoc Inc a buy or a sell?

In the last year, 10 stock analysts published opinions about TDOC-N. 2 analysts recommended to BUY the stock. 6 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Teladoc Inc.

Is Teladoc Inc a good investment or a top pick?

Teladoc Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Teladoc Inc.

Why is Teladoc Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Teladoc Inc worth watching?

10 stock analysts on Stockchase covered Teladoc Inc In the last year. It is a trending stock that is worth watching.

What is Teladoc Inc stock price?

On 2022-05-17, Teladoc Inc (TDOC-N) stock closed at a price of $32.85.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.